News/Reuters/Pharmaessentia Says To Buy 100% Forus Therapeutics For C$50 MlnPharmaessentia Says To Buy 100% Forus Therapeutics For C$50 MlnRead the full articleGet unlimited access to articles from Reuters and every other news source on TradingView.Keep reading